Communicable

Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?


Listen Later

CMI Communications editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global (ECCMID) in Barcelona, providing insights into the trials’ designs, results, and implications. The DOTS trial compared two doses of long-acting dalbavancin to standard of care in patients with complicated S. aureus bacteremia. GAME-CHANGER compared cefiderocol to standard of care for gram-negative infections. PediCAP compared oral step-down therapy with amoxicillin with or without clavulanic acid at shorter durations to the current WHO-recommended standard of five days of intravenous antibiotic therapy in children with severe pneumonia. Additional results from the MULTICAP and CLEEN trials, the CAMERA-2 follow-on in vitro analysis, and the Burkina Faso Escherichia coli transmission study are also discussed. Episode peer-reviewed by Dr. Yousra Kherabi.

...more
View all episodesView all episodes
Download on the App Store

CommunicableBy CMI Communications

  • 5
  • 5
  • 5
  • 5
  • 5

5

3 ratings


More shows like Communicable

View all
This Week in Virology by Vincent Racaniello

This Week in Virology

2,050 Listeners

This Week in Microbiology by Vincent Racaniello

This Week in Microbiology

514 Listeners

Let's Talk ID by Infectious Diseases Society of America (IDSA)

Let's Talk ID

130 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

488 Listeners

Editors in Conversation by American Society for Microbiology

Editors in Conversation

27 Listeners

This Week in Virology by Vincent Racaniello

This Week in Virology

223 Listeners

The Clinical Problem Solvers by The Clinical Problem Solvers

The Clinical Problem Solvers

512 Listeners

Breakpoints by Society of Infectious Diseases Pharmacists

Breakpoints

159 Listeners

Febrile by Sara Dong

Febrile

188 Listeners

ID:IOTS - Infectious Disease Insight Of Two Specialists by Infectious Disease: Insights of Two Specialists

ID:IOTS - Infectious Disease Insight Of Two Specialists

25 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,044 Listeners

Infectious Disease Puscast by Vincent Racaniello

Infectious Disease Puscast

82 Listeners

The Rest Is Politics: Leading by Goalhanger

The Rest Is Politics: Leading

802 Listeners

Joint Approach by Musculoskeletal Infection Society/European Bone and Joint Infection Society

Joint Approach

7 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,145 Listeners